Reducing the burden of disclosure for public biotech companies
Crossref DOI link: https://doi.org/10.1038/nbt.2888
Published Online: 2014-05-08
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Evans, Robert III
Kessel, Mark
Text and Data Mining valid from 2014-05-01
Article History
First Online: 8 May 2014
Competing interests
: The authors declare no competing financial interests.